Annovis Bio files warrant purchase agreement for non-controlled affairs of unaudited financial statements.

The Company filed an exhibit related to a Warrant to Purchase Common Stock that lacks disclosed terms. The filing indicates the potential for future equity dilution, which is a technical corporate milestone rather than a market-moving financial event.